» Articles » PMID: 22086517

M2-polarized Tumor-associated Macrophages Are Associated with Poor Prognoses Resulting from Accelerated Lymphangiogenesis in Lung Adenocarcinoma

Overview
Publisher Elsevier
Specialty General Medicine
Date 2011 Nov 17
PMID 22086517
Citations 94
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Tumor-associated macrophages have been implicated in promoting tumor growth, progression and metastasis. However, the activated phenotype (M1 or M2) of tumor-associated macrophages remains unknown in solid tumors. Therefore, this study examined the density and prognostic significance of M2-polarized tumor-associated macrophages in lung adenocarcinoma.

Methods: Tumor specimens from 65 lung adenocarcinoma patients were assessed by ELISA for Th1/Th2 cytokine concentrations. The activated phenotype (M1 or M2) of tumor-associated macrophages was determined utilizing immunofluorescence staining. Additionally, to evaluate lymphangiogenesis, peritumoral lymphatic microvessel density was measured using D2-40. The correlation between tumor-associated macrophage subtype and overall patient survival was analyzed using the Kaplan-Meier method and compared using the log-rank test.

Results: A shift toward Th2 cytokine expression was detected within lung adenocarcinoma microenvironments. Approximately 79.71±16.27% of tumor-associated macrophages were M2 polarized; the remaining 20.35±5.31% were M1 polarized. The infiltration of M2-polarized macrophages was significantly associated with P-TNM staging and lymph node metastasis. The peritumoral lymphatic microvessel density was significantly higher in the high M2-polarized tumor-associated macrophage group than in the low M2-polarized tumor-associated macrophage group. A significant difference in overall patient survival was detected not only between patients with tumors with high and low macrophage counts but also between patients with tumors with high and low counts of M2-polarized macrophages.

Conclusion: Tumor-associated macrophages in lung adenocarcinoma have an M2-polarized subtype and are associated with poor prognoses, perhaps resulting from accelerated lymphangiogenesis and lymph node metastasis.

Citing Articles

Pathogenetic Mechanisms Linking Sarcoidosis to Lymphoma.

Voutidou S, Eleftheriadis D, Drakopanagiotakis F, Papanikolaou I, Steiropoulos P Int J Mol Sci. 2025; 26(2).

PMID: 39859309 PMC: 11765988. DOI: 10.3390/ijms26020594.


Visualizing the Tumor Microenvironment: Molecular Imaging Probes Target Extracellular Matrix, Vascular Networks, and Immunosuppressive Cells.

Chan H, Kuo D, Shueng P, Chuang H Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770505 PMC: 11676442. DOI: 10.3390/ph17121663.


Holliday junction recognition protein (HJURP) could reflect the clinical outcomes of lung adenocarcinoma patients, and impact the choice of precision therapy.

Gao X, Zhang Y, Zhang M, Sun Y Front Genet. 2024; 15:1475511.

PMID: 39649097 PMC: 11621083. DOI: 10.3389/fgene.2024.1475511.


New insights into macrophage polarization and its prognostic role in patients with colorectal cancer liver metastasis.

Khanduri I, Maki H, Verma A, Katkhuda R, Anandappa G, Pandurengan R BJC Rep. 2024; 2(1):37.

PMID: 39516662 PMC: 11523988. DOI: 10.1038/s44276-024-00056-8.


Paeonia genus: a systematic review of active ingredients, pharmacological effects and mechanisms, and clinical applications for the treatment of cancer.

Zhou X, Alimu A, Zhao J, Xu X, Li X, Lin H Arch Pharm Res. 2024; 47(8-9):677-695.

PMID: 39306813 DOI: 10.1007/s12272-024-01512-2.


References
1.
Schoppmann S, Fenzl A, Nagy K, Unger S, Bayer G, Geleff S . VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survival. Surgery. 2006; 139(6):839-46. DOI: 10.1016/j.surg.2005.12.008. View

2.
Schoppmann S, Birner P, Stockl J, Kalt R, Ullrich R, Caucig C . Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol. 2002; 161(3):947-56. PMC: 1867252. DOI: 10.1016/S0002-9440(10)64255-1. View

3.
Stein M, Keshav S, Harris N, Gordon S . Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med. 1992; 176(1):287-92. PMC: 2119288. DOI: 10.1084/jem.176.1.287. View

4.
Gordon S . Alternative activation of macrophages. Nat Rev Immunol. 2003; 3(1):23-35. DOI: 10.1038/nri978. View

5.
Zhang B, Wang J, Gao J, Guo Y, Chen X, Wang B . Alternatively activated RAW264.7 macrophages enhance tumor lymphangiogenesis in mouse lung adenocarcinoma. J Cell Biochem. 2009; 107(1):134-43. DOI: 10.1002/jcb.22110. View